American Century Companies’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-134,021
Closed -$815K 1504
2014
Q3
$815K Buy
+134,021
New +$915K ﹤0.01% 1218
2014
Q2
Sell
-24,980
Closed -$595K 1546
2014
Q1
$595K Buy
+24,980
New +$362K ﹤0.01% 1321
2013
Q3
Sell
-180,983
Closed -$2.38M 1535
2013
Q2
$2.38M Buy
+180,983
New +$2.44M ﹤0.01% 1051

Other funds holding ECYT

American Century Companies's ECYT Position: Q4 2014 in Review

American Century Companies sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2014, closing a stake of 134,021 shares — an estimated $815K sold.

American Century Companies first reported a position in ECYT in Q2 2013 and held it in 3 quarters. The position peaked at $2.38M in Q2 2013. 100 funds tracked by Wall St. Rank hold ECYT as of Q4 2014.

  • American Century Companies reported no remaining Endocyte, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • American Century Companies sold 134,021 Endocyte, Inc. Common Stock shares in Q4 2014, an estimated $815K.
  • American Century Companies first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 3 quarters.
  • American Century Companies's Endocyte, Inc. Common Stock position peaked at $2.38M in Q2 2013.
  • 100 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2014.

Based on American Century Companies's 13F filing for Q4 2014, filed 27 Jan 2015.